(Allergan plc)

	AGN latest price $291.0645 (-2.54%) ($287.6189 - $299.8957) on Fri. Nov. 6, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.74% (three month average)
RSI	65
Latest Price	$291.0645(-2.54%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.4% a day on average for past five trading days.
Weekly Trend	AGN advances 8% a week on average for past two weeks.
Market Behavior	Normal for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(52%)    IBB(50%)    XBI(44%)    ARKG(41%)    IVW(41%)
Factors Impacting AGN price	AGN will decline at least -1.37% in a week (0% probabilities).   VIXM(-30%)    TLT(-17%)    UUP(-9%)    SHY(-7%)    GDXJ(-5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.37% (StdDev 2.74%)
Hourly BBV	0 ()
Intraday Trend	-2.5%

5 Day Moving Average	$297.83(-2.27%)
10 Day Moving Average	$290.17(0.31%)
20 Day Moving Average	$274.81(5.91%)
To recent high	-6.3%
To recent low	19.6%
Market Cap	$95.964b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed